RIAA Suggestions for content of ACTA
Written by James Love
Thursday, 26 June 2008
These are the substantive suggestions for provisions of the ACTA that the RIAA sent to the USTR on March 17, 2008.
Search Results for: ustr
Pharmaceutical Counterfeiting
What Are Counterfeit Medicines?
The definition of a counterfeit medicine is not well established. In 1992, the WHO defined a counterfeit medicine as: “a medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source." Under this definition, it is the deliberate mislabeling of a drug or medicine which makes it a counterfeit. The US FDA uses a similar definition,
Terms of Protection for Copyright and Related Rights in multilateral treaties
To provide some context to discussions on the term of protection for copyright and related rights, the following note sumarizes on the basic provisions in various multilateral copyright and related rights treaties, on the topics of minimum terms and formalities. … Continue Reading
Experts comment on Senate bill that replaces monopolies for medicines with system of prizes
Written by James Love Continue Reading
News reports and blogs on innovation prizes
Return to KEI page on prizes to stimulate innovation
A separate page on academic and other technical papers and comments on prizes is available
here:
News Reports and Blogs on Innovation Prizes
KEI Comments to EWG 2nd Web-based Public Hearing: Defending the Status Quo, or Roadmap for Change?
On Saturday, KEI filed comments with the WHO EWG’s 2nd web based hearing. Our comments focused on the criteria for new proposals. Continue Reading
Scholarly and Technical Articles and Books on Innovation Prizes
This paper has now been replaced by an updated version here: /prizes/cites
—————
An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes
KEI Research Note 2008:2
(Updated October 4, 2010)
2010. William Fisher and Talha Syed. Drugs, Law, and the Health Crisis in the Developing World. Stanford University Press. [link] Continue Reading
Prominent Innovation Prizes And Reward Programs
This has been replaced by 2008:1 Selected Innovation Prizes and Reward Programs.
PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
KEI Research Note 2007:1
Benjamin Krohmal*
March 1, 2007
Reimbursement Categories of Medicines in European Union Member Countries
Source: EUROMEDSTAT (http://www.euromedstat.cnr.it/reports/reports_reimbursement_categories.asp)
AUSTRIA
"Heilmittelverzeichnis": Pharmaceuticals listed on the "Heilmittelverzeichnis" (Pharmaceutical List) qualify for automatic reimbursement (100%)
Continue Reading
KEI issues report on Selected Innovation Prizes and Reward Programs
Written by James Love
Thursday, 20 March 2008
On March 20, 2008, KEI published "Selected Innovation Prizes and Reward Programs" (cite as KEI Research Note 2008:1). The paper, which is available on the Internet here: https://www.keionline.org/misc-docs/research_notes/kei_rn_2008_1.pdf, provides the most comprehensive account of historical uses of prizes to induce innovation now available. The introduction to the 51 page report follows: